Submit Deal

Submit Deal

Cover Image Pablo Legorreta

Pablo Legorreta

Founder and CEO at ROYALTY PHARMA

Investor

Deal Bio

Total Deals6

Valued Deals6

Total Value£ 4.20 B

Avg. Deal Size£ 700 M

Market Context

Sort

30 Jun 2022|United States|Pharmaceuticals

Target: GAVRETO

Bidder: ROYALTY PHARMA

7 Service Providers

4 Bidder | 3 Vendor

3 Dealmakers

1 Bidder | 2 Vendor

£ 279 M

Value

13 Jul 2022|United States|Pharmaceuticals

Target: THERAVANCE RESPIRATORY COMPANY

Bidder: ROYALTY PHARMA

15 Service Providers

3 Target | 4 Bidder | 8 Vendor

31 Dealmakers

11 Target | 1 Bidder | 19 Vendor

£ 1.35 B

Value

09 Jan 2023|United States|Biotechnology

Target: IONIS PHARMACEUTICALS

Bidder: ROYALTY PHARMA

7 Service Providers

3 Target | 4 Bidder

10 Dealmakers

9 Target | 1 Bidder

£ 930 M

Value

07 Nov 2024|United States|Biotechnology

Target: GERON CORPORATION

Bidder: ROYALTY PHARMA

8 Service Providers

3 Target | 5 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 290 M

Value

10 Jan 2025|United States|Real Estate Services

Target: RP MANAGEMENT INC

Bidder: ROYALTY PHARMA

6 Service Providers

2 Target | 4 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 893 M

Value

14 Oct 2025|United States|Pharmaceuticals

Target: KAILERA THERAPEUTICS

Bidder: ROYALTY PHARMA

16 Service Providers

1 Target | 15 Bidder

32 Dealmakers

2 Target | 30 Bidder

£ 449 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Pablo Legorreta